Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksBuy Aurobindo Pharma; target of Rs 915: Motilal Oswal

    Buy Aurobindo Pharma; target of Rs 915: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 915 in its research report dated March 06, 2017.

    March 07, 2017 / 12:39 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More
      Motilal Oswal's report onAurobindo Pharma
      Aurobindo Pharma (ARBP) recorded 7% QoQ decline (down 13% YoY) in the US base business for 3Q, leading to concerns about the US business growth outlook. We believe this a one-off event as the company faces least product concentration risk among peers.
      Outlook
      With the recent acquisition in EU (Actavis assets) and US (Natrol), the share of high-margin formulations in total revenues has increased to 80% (v/s 54% in FY10), positioning it among large-cap formulation players. Our target price of INR 915 discounts ARBP’s 1HFY19E EPS at 18x P/E multiple.
      For all recommendations, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

      Read More Read More

      first published: Mar 7, 2017 12:39 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347